Syensqo begins review of segment

Syensqo has initiated a strategic review of its Performance & Care segment as part of its aim of becoming a pure play speciality materials and advanced technologies company, with a greater exposure to “structurally attractive end markets”, such as aerospace and defence, electronics, healthcare, energy and advanced mobility. No defined timetable has been set.

The segment, comprising the Novecare and Technology Solutions global business units, is active in surface chemistry and speciality mining reagents for the consumer care, agro, coatings and mining markets. In 2025, it had net sales of €2.0 billion and an underlying EBITDA of €358 million.